Skip to main content

Primary testicular lymphoma: the site matters.

Publication ,  Journal Article
Stefanovic, A; Lossos, IS
Published in: Leuk Lymphoma
July 2010

Duke Scholars

Published In

Leuk Lymphoma

DOI

EISSN

1029-2403

Publication Date

July 2010

Volume

51

Issue

7

Start / End Page

1159 / 1160

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Testicular Neoplasms
  • Survival Rate
  • Radiotherapy Dosage
  • Male
  • Lymphoma, Large B-Cell, Diffuse
  • Immunology
  • Humans
  • Combined Modality Therapy
  • Antineoplastic Combined Chemotherapy Protocols
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stefanovic, A., & Lossos, I. S. (2010). Primary testicular lymphoma: the site matters. Leuk Lymphoma, 51(7), 1159–1160. https://doi.org/10.3109/10428194.2010.481067
Stefanovic, Alexandra, and Izidore S. Lossos. “Primary testicular lymphoma: the site matters.Leuk Lymphoma 51, no. 7 (July 2010): 1159–60. https://doi.org/10.3109/10428194.2010.481067.
Stefanovic A, Lossos IS. Primary testicular lymphoma: the site matters. Leuk Lymphoma. 2010 Jul;51(7):1159–60.
Stefanovic, Alexandra, and Izidore S. Lossos. “Primary testicular lymphoma: the site matters.Leuk Lymphoma, vol. 51, no. 7, July 2010, pp. 1159–60. Pubmed, doi:10.3109/10428194.2010.481067.
Stefanovic A, Lossos IS. Primary testicular lymphoma: the site matters. Leuk Lymphoma. 2010 Jul;51(7):1159–1160.

Published In

Leuk Lymphoma

DOI

EISSN

1029-2403

Publication Date

July 2010

Volume

51

Issue

7

Start / End Page

1159 / 1160

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Testicular Neoplasms
  • Survival Rate
  • Radiotherapy Dosage
  • Male
  • Lymphoma, Large B-Cell, Diffuse
  • Immunology
  • Humans
  • Combined Modality Therapy
  • Antineoplastic Combined Chemotherapy Protocols